Abstract:Abstract Motivation Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high-efficiency approach toward rapid development of efficacious treatments. The emergence of large-scale, heterogeneous biological networks has offered unprecedented opportunities for developing in silico drug repositioning approaches. However, capturing highly non-linear, heterogeneous network structures by most existing approaches for drug repositioning has been challenging. Results In this study, we developed a network-based deep-learning approach, termed deepDR, for in silico drug repurposing by integrating 10 networks: one drug–disease, one drug-side-effect, one drug–target and seven drug–drug networks. Specifically, deepDR learns high-level features of drugs from the heterogeneous networks by a multi-modal deep autoencoder. Then the learned low-dimensional representation of drugs together with clinically reported drug–disease pairs are encoded and decoded collectively via a variational autoencoder to infer candidates for approved drugs for which they were not originally approved. We found that deepDR revealed high performance [the area under receiver operating characteristic curve (AUROC) = 0.908], outperforming conventional network-based or machine learning-based approaches. Importantly, deepDR-predicted drug–disease associations were validated by the ClinicalTrials.gov database (AUROC = 0.826) and we showcased several novel deepDR-predicted approved drugs for Alzheimer’s disease (e.g. risperidone and aripiprazole) and Parkinson’s disease (e.g. methylphenidate and pergolide). Availability and implementation Source code and data can be downloaded from https://github.com/ChengF-Lab/deepDR Supplementary information Supplementary data are available online at Bioinformatics.

DRML-Ensemble: drug repurposing method based on feature construction of multi-layer ensemble

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

DRTerHGAT: A Drug Repurposing Method Based on the Ternary Heterogeneous Graph Attention Network

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Drug repositioning based on the heterogeneous information fusion graph convolutional network

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

DrugRPE: Random Projection Ensemble Approach to Drug-Target Interaction Prediction

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy

DR3E-Net: Drug Repurposing Network Framework Based on Deep Embedding, Differentially Expressed Genes, and Drug Side Effects

deepDR: a network-based deep learning approach to in silico drug repositioning

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

DRP-VEM: Drug repositioning prediction using voting ensemble

DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Drug repositioning based on weighted local information augmented graph neural network

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning

DeepDRA: Drug repurposing using multi-omics data integration with autoencoders

A Genetic Algorithm-Based Ensemble Learning Framework for Drug Combination Prediction